Health AI Central
Share:
Peer-Reviewed Publication
Tremor Other Hyperkinet Mov (N Y)2024;1460.January 1, 2024Journal Article

Clinical and Economic Correlates of Pharmacotherapy in Patients with Essential Tremor.

Rajesh Pahwa1, Kalea Colletta2, Donald Higgins3, Bridgette Kanz Schroader4, Brian M Davis5, Liana Hennum6, Elan D Louis7,8
1University of Kansas Medical Center, Kansas City, KS, USA.
2Department of Neurology, Edward Hines Jr. VA Hospital, Hines, IL, USA.
3Research and Development, Samuel S. Stratton VA Medical Center, Albany, NY, USA.
4Cencora (previously AmerisourceBergen/Xcenda), Conshohocken, PA, USA.
5Merative, Ann Arbor, MI, USA.
6Former employee, Cala Health, San Mateo, CA, USA.
7Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
8Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Essential tremor (ET) is among the most common movement disorders, yet there are few treatment options. Medications have limited efficacy and adverse effects; thus, patients often discontinue pharmacotherapy or take several medications in combination. We evaluated the economic correlates (healthcare resource utilization [HCRU] and costs) and comorbidities among adults with and without…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.